MedicLight’s Intranasal Low Level Laser Blood Irradiation Impact on Red Blood Cell Aggregation

"Numerous low level laser therapy (“LLLT”) studies provide positive evidence on LLLT as a successful method to treat a number of diseases. It has also been tested over many years as a successful method for pain management. Our own tests on blood irradiation through intranasal light therapy have been pointing towards the conclusion that it can at least deal with diseases and health disorders related to impaired blood circulation caused by high red blood cell aggregation, hypertension being the major one.

"MedicLight’s Intranasal Low Level Laser Blood Irradiation – Impact on Red Blood Cell Aggregation" source

The greater body of scientific literature discusses the response of normal tissue cells, not red blood cells (“RBCs”) when explaining the mechanisms of LLLT. Normal tissue cells have mitochondria that respond to the light and subsequently get “bio-stimulated”. The RBCs do not have mitochondria and they constitute 95 percent of cells in the blood. Much of the rest of the blood consist of plasma. Some literature suggests that notwithstanding, RBCs do react by stimulating the release of ATP. Something else is also happening that results in the good outcomes that we are witnessing. Just focusing on RBC aggregation, it has been found that red light actually inhibits the kind of RBC aggregation we see in the figure below. The picture below is a 40x microscopy magnification of a blood sample taken from the subject before he was treated with the device."

"MedicLight’s Intranasal Low Level Laser Blood Irradiation – Impact on Red Blood Cell Aggregation" source & read more...